Breast Neoplasms - Exposure Details | CTD
Skip navigation

Disease Breast Neoplasms

These are exposure details associated with the disease and all of its children.



1–50 of 1,110 results.
  Reference Exposure Stressor Number of Receptors Receptors Receptor Notes Medium Exposure Marker Marker Level Measurement Statistic Assay Notes Country Outcome Relationship Disease Phenotype
1. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Controls for disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune 1,2-dichloroethylene 434.53 micrograms per liter concentration United States
2. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Subjects with disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
3. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Controls for disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
4. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Veterans Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
5. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Subjects with disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune 1,2-dichloroethylene 434.53 micrograms per liter concentration United States
6. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl 436 nanograms per gram lipid geometric mean PCB-138, PCB-158 United States
7. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl 386 nanograms per gram lipid geometric mean PCB-138, PCB-158 United States
8. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl United States no correlation Breast Neoplasms
9. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether 38.8 nanograms per gram lipid geometric mean United States
10. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether United States prediction/hypothesis Breast Neoplasms
11. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether 25.1 nanograms per gram lipid geometric mean United States
12. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl 632 nanograms per gram lipid geometric mean United States
13. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl United States no correlation Breast Neoplasms
14. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl 541 nanograms per gram lipid geometric mean United States
15. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 710 Subjects with disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 196 micrograms per gram creatinine 95th percentile United States
16. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 598 Controls for disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 199 micrograms per gram creatinine 95th percentile United States
17. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 598 Controls for disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 38.6 micrograms per gram creatinine median United States
18. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 710 Subjects with disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 37.7 micrograms per gram creatinine median United States
19. Wilson KM, et al. (2009). Acrylamide 90,628 Workers Nurses age 25-42 at start of study in 1989 United States no correlation Breast Neoplasms
20. Ranzi A, et al. (2011). Air Pollutants 16,193 Study subjects Metals, Heavy Italy positive correlation Breast Neoplasms
21. Freeman LE, et al. (2011). Atrazine 53,662 Workers Pesticide applicators United States no correlation Breast Neoplasms
22. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,334 Controls for disease:Breast Neoplasms Benzo(a)pyrene 0.97 relative units mean exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
23. Mordukhovich I, et al. (2015). Benzo(a)pyrene Controls for disease:Breast Neoplasms 566-597 controls Benzo(a)pyrene 196.71 relative units mean mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
24. Mordukhovich I, et al. (2015). Benzo(a)pyrene Subjects with disease:Breast Neoplasms 520-551 cases Benzo(a)pyrene 125.31 relative units interquartile range mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
25. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,334 Controls for disease:Breast Neoplasms Benzo(a)pyrene 0.55 relative units interquartile range exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
26. Mordukhovich I, et al. (2015). Benzo(a)pyrene 3,064 Study subjects mix of cases and controls for Breast Neoplasms United States positive correlation Breast Neoplasms
27. Mordukhovich I, et al. (2015). Benzo(a)pyrene 3,064 Study subjects mix of cases and controls for Breast Neoplasms United States positive correlation Breast Neoplasms
28. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,274 Subjects with disease:Breast Neoplasms Benzo(a)pyrene 1.03 relative units mean exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
29. Mordukhovich I, et al. (2015). Benzo(a)pyrene Subjects with disease:Breast Neoplasms 520-551 cases Benzo(a)pyrene 227.42 relative units mean mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
30. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,274 Subjects with disease:Breast Neoplasms Benzo(a)pyrene 0.62 relative units interquartile range exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
31. Mordukhovich I, et al. (2015). Benzo(a)pyrene Controls for disease:Breast Neoplasms 566-597 controls Benzo(a)pyrene 122.06 relative units interquartile range mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
32. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane 143 nanograms per gram lipid geometric mean United States
33. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane United States no correlation Breast Neoplasms
34. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane 158 nanograms per gram lipid geometric mean United States
35. López-Carrillo L, et al. (2010). butylbenzyl phthalate 74 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 7.22 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
36. López-Carrillo L, et al. (2010). butylbenzyl phthalate 454 Study subjects mix of 233 cases and 221 controls for Breast Neoplasms urine butylbenzyl phthalate C1/b = monobenzyl phthalate Mexico negative correlation Breast Neoplasms
37. López-Carrillo L, et al. (2010). butylbenzyl phthalate 88 Subjects with disease:Breast Neoplasms Premenopausal breast cancer patients urine butylbenzyl phthalate 5.29 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
38. López-Carrillo L, et al. (2010). butylbenzyl phthalate 233 Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate 5.43 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
39. López-Carrillo L, et al. (2010). butylbenzyl phthalate 221 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 6.27 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
40. López-Carrillo L, et al. (2010). butylbenzyl phthalate 145 Subjects with disease:Breast Neoplasms Postmenopausal breast cancer patients urine butylbenzyl phthalate 5.51 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
41. López-Carrillo L, et al. (2010). butylbenzyl phthalate 174 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 5.84 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
42. Vacchi-Suzzi C, et al. (2015). Cadmium 896 Subjects with disease:Breast Neoplasms Postmenopausal women urine Cadmium 0.67 micrograms per gram creatinine mean Denmark
43. Gallagher CM, et al. (2010). Cadmium 98 Controls for disease:Breast Neoplasms urine Cadmium 0.45 micrograms per gram creatinine median United States
44. Satarug S, et al. (2017). Cadmium 618 Study subjects mix of 618 cases and 618 controls for Breast Neoplasms Japan positive correlation Breast Neoplasms
45. Vacchi-Suzzi C, et al. (2015). Cadmium 896 Subjects with disease:Breast Neoplasms Postmenopausal women Cadmium 6.75 nanograms per kilocalorie mean Denmark
46. Itoh H, et al. (2014). Cadmium 780 Study subjects mix of 390 cases and 390 controls for Breast Neoplasms Japan no correlation Breast Neoplasms
47. Itoh H, et al. (2014). Cadmium 156 Subjects with disease:Breast Neoplasms Postmenopausal women with estrogen receptor ER+ tumors Japan positive correlation Breast Neoplasms
48. Itoh H, et al. (2014). Cadmium 390 Subjects with disease:Breast Neoplasms Cadmium 24.5 micrograms per day mean estimated exposure based on food frequency questionnaire, age-adjusted Japan
49. Vacchi-Suzzi C, et al. (2015). Cadmium 868 Controls for disease:Breast Neoplasms Postmenopausal women urine Cadmium 0.72 micrograms per gram creatinine mean Denmark
50. Satarug S, et al. (2017). Cadmium 2,976 Study subjects mix of 92 cases and 2,884 controls for Breast Neoplasms urine United States positive correlation Breast Neoplasms
1–50 of 1,110 results.